Do you ever get the feeling that you are alone? Well, stop right there! Little do you know, you are home to trillions of bacteria that all live together and go by the name of your microbiome. There are over 100 trillion microorganisms that live in your gut, mouth, skin, and other surfaces of your body, leaving you to be the farthest thing from alone.

By: Emily MacHale

Tustin, CA - Integrium, LLC Executives will be attending the American Academy of Dermatology (AAD) Annual Meeting on Friday, March 3rd, 2017 in Orlando, FL. Bringing together dermatology companies across the map each year, Integrium finds AAD Annual Meeting to be an important time to connect with key opinion leaders to discover new trends and news in the dermatology arena.

Tustin, CA - Integrium, LLC and Life Sciences Collaborative Executives will be in attendance at Why Invest in Philadelphia Now? Converting Risk Capital to Success Stories on March 7, 2017.

Agenda
Life Sciences Collaborative will host a panel of discussions during their March 2017 event.

Tustin, CA - Integrium Executives will be in Orlando during the 2017 GPhA Annual Meeting. We are eager and excited to see friends and discover new relationships in the Generic / Biosimilars / 505(b)(2) industry. Integrium is heavily involved in the generic drug sector and is interested in hearing from key note speakers as to how the generic industry continues to rapidly change and impact healthcare customers as a whole.

Tustin, CA - Integrium, LLC announced they will be attending the Redefining Early Stage Investments (RESI) Conference in San Francisco, CA on January 10, 2017. Integrium Executives are consistent attendees of RESI Conference and look to create new relationships within the biotech and investing realm.

Integrium will be in San Francisco during
J.P. Morgan 35th Annual Healthcare Conference 2017
Looking to expand your network in the biotech, medical device or
diagnostics field? Secure your spot to meet with us today!

Integrium is a full-service Clinical Proof of Concept (PoC) Firm focused within the therapeutic areas of Cardiovascular, Metabolic, Renal, Inflammatory, Dermatology, Wound Healing, Regenerative, and Orphan Disease.

Tustin, CA – Integrium, LLC announced they will be attending the Redefining Early Stage Investments (RESI) Conference on September 13, 2016 in Boston, MA. Integrium has attended numerous RESI Conferences in the past and has been able to develop key relationships through workshops, panels, and group discussions.

Ying focuses on following a healthy life schedule combined with Western and Eastern medicine. She enjoys great tasting food, except ones with strong bitter flavors!

Her favorite vacation spot is any place near water (but staying away from mosquitos) and has traveled to many places including Toronto, Korea, Thailand, Middle and Southwest China, California, Washington D.C., Philadelphia, Boston, and New York.

By Emily MacHale
July 5, 2016

The Biosimilar market is estimated to save the United States over $44 billion by 2024 when many branded biologics are coming off patent protection.

Slightly different from generics and biological reference products, biosimilars are complex in their manufacturing and data, leaving the FDA to confirm its’ safety and efficacy to pass regulations.

By Emily MacHale

May 2, 2016

After an exciting event, Integrium would like to thank all attendees that were able to join us in discussing 4 Keys to a Successful Proof of Concept and Alternative Financing on Wednesday, April 20th. Integrium's goal was to provide additional knowledge and understanding behind the strategy of holding a Proof of Concept clinical trial and key factors that go into it.